Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture

The emerging SARS-CoV-2 infection associated with the outbreak of viral pneumonia in China is ongoing worldwide. There are no approved antiviral therapies to treat this viral disease. Here we examined the antiviral abilities of three broad-spectrum antiviral compounds gemcitabine, lycorine and oxyso...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Emerg Microbes Infect
Hlavní autoři: Zhang, Ya-Nan, Zhang, Qiu-Yan, Li, Xiao-Dan, Xiong, Jin, Xiao, Shu-Qi, Wang, Zhen, Zhang, Zhe-Rui, Deng, Cheng-Lin, Yang, Xing-Lou, Wei, Hong-Ping, Yuan, Zhi-Ming, Ye, Han-Qing, Zhang, Bo
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
Letter
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448857/
https://ncbi.nlm.nih.gov/pubmed/32432977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/22221751.2020.1772676
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky